期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
痛风金黄凝胶贴膏的质量标准研究
1
作者 卢勇 章斌 +2 位作者 杨亚 赵松梅 李飞 《广东化工》 CAS 2024年第17期164-166,160,共4页
目的:建立痛风金黄凝胶贴膏的薄层鉴别及含量测定方法,并进行制剂检查。方法:采用薄层色谱法(TLC)建立制剂中冰片、黄柏、大黄的鉴别方法;采用高效液相色谱法(HPLC)建立制剂中盐酸小檗碱的含量测定方法;进行含膏量、赋形性、黏附力和微... 目的:建立痛风金黄凝胶贴膏的薄层鉴别及含量测定方法,并进行制剂检查。方法:采用薄层色谱法(TLC)建立制剂中冰片、黄柏、大黄的鉴别方法;采用高效液相色谱法(HPLC)建立制剂中盐酸小檗碱的含量测定方法;进行含膏量、赋形性、黏附力和微生物限度检查。结果:薄层色谱鉴别斑点清晰、阴性无干扰、分离度好。盐酸小檗碱质量浓度在7.1469μg/mL~71.4688μg/mL范围内与其峰面积线性关系良好(r^(2)=0.9994),平均加样回收率98.49%(RSD 1.46%)。含膏量、赋形性、黏附力和微生物限度检查均符合规定。结论:所建立的方法简便可行、准确度高,可用于痛风金黄凝胶贴膏的质量控制。 展开更多
关键词 痛风金黄散 凝胶贴膏 盐酸小檗碱 TLC HPLC
下载PDF
Efficacy of Zhumian Tang formula granules(助眠汤配方颗粒)combined with eszopiclone for the treatment of poor sleep quality:a multi-center,randomized controlled,superiority trial 被引量:1
2
作者 WANG Yichen WU Shiyi +8 位作者 WANG Zhengyan CHANG Wenling XIE Zhihao TANG Xing zhao songmei ZHOU Jing CHEN Zehong WANG Chao() YANG Chunxia 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2024年第1期163-171,共9页
OBJECTIVE:To evaluate the efficacy and safety of Zhumian Tang formula granules(助眠汤配方颗粒)combined with eszopiclone for treating poor sleep quality.METHODS:This multi-center,dynamic blockrandomized,parallel-group ... OBJECTIVE:To evaluate the efficacy and safety of Zhumian Tang formula granules(助眠汤配方颗粒)combined with eszopiclone for treating poor sleep quality.METHODS:This multi-center,dynamic blockrandomized,parallel-group superiority clinical trial included 130 patients.The combined treatment group received Zhumian Tang formula granules combined with eszopiclone treatment,and the control group received eszopiclone treatment only.The group allocation ratio was 1∶1.The duration of treatment was 2 weeks.Participants were asked to complete questionnaires before treatment,after 1 week of the intervention,after 2 weeks of the intervention,and at the follow-up on week 3.The primary outcomes were the Pittsburgh Sleep Quality Index(PSQI)score and the total effective rate of treatment.The secondary outcome was the rate of adverse effects.RESULTS:Compared with the eszopiclone treatment group,the PSQI score of the combined treatment group was significantly lower after 2 weeks of the intervention(6.98 vs 8.26,P<0.05).However,there was no significant difference in the mean PSQI score after 1 week of the intervention(9.89 vs 9.15,P=0.124).After the follow-up on week 3,the PSQI score of the combined treatment group remained significantly lower than that of the eszopiclone treatment group(6.12 vs 8.31,P<0.001).The total effective rates of treatment of the combined group and the eszopiclone group were 36.92%vs 35.38%(Z=0.033,P=0.855)after 1 week of the intervention,83.08%vs 58.46%(Z=9.519,P<0.05)after 2 weeks of the intervention,and 83.08%vs 61.54%(Z=7.530,P<0.05)and after the follow-up on week 3,respectively.There was no significant difference in the overall rate of adverse reactions between the combined and eszopiclone treatment groups(21.53%vs 31.8%,P=0.318).CONCLUSION:The combination of Zhumian Tang formula granules with eszopiclone was found to be safe and more effective in improving sleep quality than eszopiclone alone.Traditional Chinese medicine can enhance the effectiveness of Western medicine in the treatment of insomnia. 展开更多
关键词 sleep quality ESZOPICLONE randomized controlled trial SUPERIORITY Zhumian Tang formula granules
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部